Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | B3GNT3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
mRNA | C11orf49 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | UBE2V2 | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
mRNA | KRT13 | CCLE | pan-cancer | AAC | 0.19 | 0.0004 |
mRNA | UBE2D1 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
mRNA | KLF3 | CCLE | pan-cancer | AAC | 0.18 | 0.0004 |
mRNA | CXCL11 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
mRNA | RPS20 | FIMM | pan-cancer | AAC | 0.63 | 0.0004 |
mRNA | GK | CCLE | pan-cancer | AAC | -0.19 | 0.0004 |
mRNA | S100A14 | CCLE | pan-cancer | AAC | 0.2 | 0.0004 |